An alteration of the gut-liver axis drives pulmonary inflammation after intoxication and burn injury in mice

Am J Physiol Gastrointest Liver Physiol. 2014 Oct 1;307(7):G711-8. doi: 10.1152/ajpgi.00185.2014. Epub 2014 Aug 7.

Abstract

Approximately half of all adult burn patients are intoxicated at the time of their injury and have worse clinical outcomes than those without prior alcohol exposure. This study tested the hypothesis that intoxication alters the gut-liver axis, leading to increased pulmonary inflammation mediated by burn-induced IL-6 in the liver. C57BL/6 mice were given 1.2 g/kg ethanol 30 min prior to a 15% total body surface area burn. To restore gut barrier function, the specific myosin light chain kinase inhibitor membrane-permeant inhibitor of kinase (PIK), which we have demonstrated to reduce bacterial translocation from the gut, was administered 30 min after injury. Limiting bacterial translocation with PIK attenuated hepatic damage as measured by a 47% reduction in serum alanine aminotransferase (P < 0.05), as well as a 33% reduction in hepatic IL-6 mRNA expression (P < 0.05), compared with intoxicated and burn-injured mice without PIK. This mitigation of hepatic damage was associated with a 49% decline in pulmonary neutrophil infiltration (P < 0.05) and decreased alveolar wall thickening compared with matched controls. These results were reproduced by prophylactic reduction of the bacterial load in the intestines with oral antibiotics before intoxication and burn injury. Overall, these data suggest that the gut-liver axis is deranged when intoxication precedes burn injury and that limiting bacterial translocation in this setting attenuates hepatic damage and pulmonary inflammation.

Keywords: IL-6; ethanol; myosin light chain kinase; steatosis; trauma.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alcoholic Intoxication / complications*
  • Alcoholic Intoxication / drug therapy
  • Alcoholic Intoxication / immunology
  • Alcoholic Intoxication / metabolism
  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Translocation* / drug effects
  • Burns / complications*
  • Burns / drug therapy
  • Burns / immunology
  • Burns / metabolism
  • Disease Models, Animal
  • Ethanol
  • Fatty Liver / immunology
  • Fatty Liver / metabolism
  • Fatty Liver / prevention & control
  • Inflammation Mediators / metabolism
  • Interleukin-6 / metabolism
  • Intestines / drug effects
  • Intestines / enzymology
  • Intestines / immunology
  • Intestines / microbiology*
  • Liver / drug effects
  • Liver / immunology
  • Liver / metabolism*
  • Lung / drug effects
  • Lung / immunology
  • Lung / metabolism*
  • Male
  • Mice, Inbred C57BL
  • Myosin-Light-Chain Kinase / antagonists & inhibitors
  • Myosin-Light-Chain Kinase / metabolism
  • Neutrophil Infiltration
  • Pneumonia / etiology*
  • Pneumonia / immunology
  • Pneumonia / metabolism
  • Pneumonia / prevention & control
  • Protein Kinase Inhibitors / pharmacology
  • Signal Transduction

Substances

  • Anti-Bacterial Agents
  • Inflammation Mediators
  • Interleukin-6
  • Protein Kinase Inhibitors
  • interleukin-6, mouse
  • Ethanol
  • Myosin-Light-Chain Kinase